A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men

Autor: Wagensveld, I.M., Osses, D.F., Groenendijk, P.M., Zijta, F.M., Busstra, M.B., Rociu, E., Barentsz, J.O., Sedelaar, J.P.M., Arbeel, B., Roeleveld, T., Geenen, R., Koeter, I., Meer, S.A. van der, Cappendijk, V., Somford, R., Klaver, S., Lely, H. Van der, Wolters, T., Hellings, W., Leter, M.R., Poel, H.G. van der, Heijmink, S., Debruyne, F., Immerzeel, J., Leijte, J., Roermund, J. van, Miclea, R., Planken, E., Vis, Andre N., Jong, I. de, Tijsterman, J., Wolterbeek, D., Claessen, A., Vrijhof, E., Nederend, J., Leenders, G. van, Bangma, Chris H., Krestin, G.P., Remmers, S., Schoots, I.G., Group, M.-M.W.

Publikováno v: European Urology, 82(3), 318-326. ELSEVIER SCIENCE BV
European Urology, 82(3), 318-326. Elsevier
European Urology, 82, 3, pp. 318-326
MR-PROPER Study Group 2022, ' A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging–directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men ', European Urology, vol. 82, no. 3, pp. 318-326 . https://doi.org/10.1016/j.eururo.2022.03.003
European Urology, 82, 318-326

Contains fulltext : 283332.pdf (Publisher’s version ) (Open Access) BACKGROUND: European Association of Urology guidelines recommend a risk-adjusted biopsy strategy for early detection of prostate cancer in biopsy-naive men. It remains unclear whic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78cd194599c1f8aba6029ed2dae59782
https://pubmed.ncbi.nlm.nih.gov/35341658

A0749 - A prospective multicenter comparison study of a risk-adapted ultrasound-directed and MRI-directed diagnostic pathway in prostate cancer suspected biopsy naïve men

Autor: Wagensveld, I.M., Osses, D.F., Groenendijk, P.M., Zijta, F.M., Busstra, M.B., Rociu, E., Barentsz, J.O., Sedelaar, J.P.M, Arbeel, B., Roeleveld, T., Geenen, R., Koeter, I., Van Der Meer, S.A., Cappendijk, V., Somford, R., Klaver, S., Van Der Lely, H., Wolters, T., Hellings, W., Leter, M.R., Van Der Poel, H.G., Heijmink, S.W.T.P.J., Debruyne, F., Immerzeel, J., Schoots, I.G.

Publikováno v: In European Urology February 2022 81 Supplement 1:S1111-S1112

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

817P - Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI: An observational study in the Netherlands

Autor: Westgeest, H.M., Kuppen, M., van den Eertwegh, A.J.M., Van Moorselaar, J., Mehra, N., van Oort, I., van den Bergh, A.C.M., Coenen, J.L., Aben, K.K.H., Somford, R., de Wit, R., Bergman, A., Lavalaye, J., Uyl-de Groot, C.A., Gerritsen, W.R.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8